E
Diagnos Inc. ADK.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -55.33% -45.57% -33.73% 6.47% -11.30%
Total Depreciation and Amortization -6.81% -10.98% 10.80% 11.00% 46.88%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -27.79% 32.33% 8.53% 14.53% 9.84%
Change in Net Operating Assets -215.12% -140.94% 27.76% -395.25% -58.87%
Cash from Operations -124.57% -62.62% -50.63% -20.47% -40.92%
Capital Expenditure -21.43% -130.77% -18.18% -- 89.55%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -266.78% -825.71% -- -63.64% -60.42%
Cash from Investing -269.57% -841.91% -25,013.64% -62.83% -59.32%
Total Debt Issued -- -- -- -- -100.00%
Total Debt Repaid -553.63% -11.67% -32.17% -48.33% 71.74%
Issuance of Common Stock 250.63% 141.49% 1,219.70% 405.49% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 17.35% 5.54% -27.66% -46.23% -2.66%
Cash from Financing 245.60% 165.66% 2,179.92% 13.67% 1,833.33%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -84.95% -1,098.41% 236.60% -181.82% -14.83%